Group One Trading
NKTR icon

Group One Trading’s Nektar Therapeutics NKTR Stock Holding History

Group One Trading’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.2M Sell
30,600
-107,600
-78% -$6.13M ﹤0.01% 1985
2025
Q4 		$5.84M Buy
138,200
+18,200
+15% +$1.02M 0.01% 1344
2025
Q3 		$6.83M Sell
120,000
-55,200
-32% -$1.83M 0.01% 1207
2025
Q2 		$4.53M Buy
175,200
+172,820
+7,261% +$1.94M 0.01% 1399
2025
Q1 		$24.3K Sell
2,380
-840
-26% -$11K ﹤0.01% 5688
2024
Q4 		$44.9K Sell
3,220
-733
-19% -$12.9K ﹤0.01% 5136
2024
Q3 		$77.1K Buy
3,953
+3,933
+19,665% +$75K ﹤0.01% 4373
2024
Q2 		$372 Sell
20
-9,253
-100% -$195K ﹤0.01% 6482
2024
Q1 		$130K Buy
+9,273
New +$97.1K ﹤0.01% 3911
2023
Q4 		– Sell
-600
Closed -$5.36K – 7906
2023
Q3 		$5.36K Sell
600
-473
-44% -$4.55K ﹤0.01% 6667
2023
Q2 		$9.26K Buy
1,073
+646
+151% +$6.89K ﹤0.01% 6435
2023
Q1 		$4.5K Buy
427
+254
+147% +$7.68K ﹤0.01% 6326
2022
Q4 		$5.88K Sell
173
-8,634
-98% -$418K ﹤0.01% 6267
2022
Q3 		$423K Sell
8,807
-3,106
-26% -$185K ﹤0.01% 3394
2022
Q2 		$679K Sell
11,913
-4,354
-27% -$275K ﹤0.01% 3145
2022
Q1 		$1.31M Buy
16,267
+10,374
+176% +$1.54M ﹤0.01% 2815
2021
Q4 		$1.19M Buy
5,893
+1,413
+32% +$307K ﹤0.01% 3173
2021
Q3 		$1.21M Buy
4,480
+2,893
+182% +$696K ﹤0.01% 3207
2021
Q2 		$408K Sell
1,587
-513
-24% -$142K ﹤0.01% 4454
2021
Q1 		$630K Sell
2,100
-4,327
-67% -$1.35M ﹤0.01% 3765
2020
Q4 		$1.64M Sell
6,427
-2,440
-28% -$631K ﹤0.01% 2210
2020
Q3 		$2.21M Sell
8,867
-226
-2% -$71.1K 0.01% 1518
2020
Q2 		$3.16M Buy
9,093
+1,253
+16% +$391K 0.01% 1132
2020
Q1 		$2.1M Sell
7,840
-2,620
-25% -$810K 0.02% 1011
2019
Q4 		$3.39M Buy
10,460
+4,807
+85% +$1.39M 0.02% 910
2019
Q3 		$1.54M Buy
5,653
+1,740
+44% +$638K 0.01% 1405
2019
Q2 		$2.09M Buy
3,913
+3,460
+764% +$1.73M 0.02% 1049
2019
Q1 		$228K Sell
453
-6,494
-93% -$3.85M ﹤0.01% 2597
2018
Q4 		$3.42M Sell
6,947
-940
-12% -$567K 0.03% 686
2018
Q3 		$7.21M Sell
7,887
-3,520
-31% -$3M 0.06% 400
2018
Q2 		$8.36M Buy
11,407
+6,887
+152% +$7.94M 0.07% 312
2018
Q1 		$7.2M Sell
4,520
-2,700
-37% -$3.48M 0.07% 328
2017
Q4 		$6.47M Buy
7,220
+2,667
+59% +$1.58M 0.05% 510
2017
Q3 		$1.64M Buy
4,553
+3,146
+224% +$984K 0.01% 1201
2017
Q2 		$413K Sell
1,407
-2,206
-61% -$638K ﹤0.01% 2107
2017
Q1 		$1.27M Sell
3,613
-167
-4% -$37.5K 0.01% 1168
2016
Q4 		$696K Buy
3,780
+2,067
+121% +$420K 0.01% 1558
2016
Q3 		$442K Sell
1,713
-427
-20% -$110K ﹤0.01% 1908
2016
Q2 		$457K Buy
2,140
+827
+63% +$185K 0.01% 1795
2016
Q1 		$271K Sell
1,313
-1,040
-44% -$200K ﹤0.01% 2124
2015
Q4 		$595K Sell
2,353
-207
-8% -$42.6K 0.01% 1681
2015
Q3 		$421K Sell
2,560
-4,753
-65% -$841K 0.01% 1915
2015
Q2 		$1.37M Buy
7,313
+320
+5% +$55.1K 0.02% 976
2015
Q1 		$1.15M Buy
6,993
+6,180
+760% +$1.27M 0.02% 958
2014
Q4 		$189K Sell
813
-967
-54% -$207K ﹤0.01% 2345
2014
Q3 		$322K Sell
1,780
-187
-10% -$35.8K 0.01% 1975
2014
Q2 		$378K Buy
1,967
+707
+56% +$125K 0.01% 1871
2014
Q1 		$229K Sell
1,260
-920
-42% -$182K ﹤0.01% 2331
2013
Q4 		$371K Sell
2,180
-5,107
-70% -$824K 0.01% 1886
2013
Q3 		$1.14M Buy
7,287
+5,334
+273% +$986K 0.02% 921
2013
Q2 		$338K Buy
+1,953
New +$300K 0.01% 1682

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Group One Trading's NKTR Position: Q1 2026 in Review

Group One Trading increased its Nektar Therapeutics (NKTR) stake by 311% in Q1 2026, buying an estimated $256K and bringing the position to 5,949 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #3485.

Group One Trading first reported a position in NKTR in Q2 2013 and has held it in 40 quarters since. The position peaked at $14.8M in Q1 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Group One Trading held 5,949 shares of Nektar Therapeutics worth $428K as of Q1 2026.
  • Group One Trading bought 4,501 Nektar Therapeutics shares in Q1 2026, an estimated $256K.
  • Nektar Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3485 holding.
  • Group One Trading first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 40 quarters since.
  • Group One Trading's Nektar Therapeutics position peaked at $14.8M in Q1 2018.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.